Sirolimus Eluting Coronary Stent System
- UID
- MFG/MD/2020/000228_dd9e936185c45bb38483da5470752fd4_3117233600b5998cc878622c80f418a2
- Device class
- Class D
- Brand name
- Focus np, Abluminus np, Cynosure
- License holder
- Envision Scientific Pvt. Ltd.
- Approving authority
- Central Drug Standards Control Organization, Ahmedabad
- Product information
- The Sirolimus Eluting Coronary Stent System is indicated for treatment of patients with stenosis in coronary arteries. It is indicated for improving and maintaining the coronary luminal diameter in patients. The Sirolimus Eluting Coronary Stent System is indicated to treat coronary artery disease in patients with Diabetes Mellitus and lesion in coronary artery with diffused proliferative disease. The Sirolimus Eluting Coronary Stent System is indicated for treatment of symptomatic ischemic disease with diabetes mellitus due to lesions of length ≤ 52 mm in native coronary arteries with a reference diameter from 2.25mm to 5.00mm
Sirolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000228_dd9e936185c45bb38483da5470752fd4_3117233600b5998cc878622c80f418a2. This device is marketed under the brand name Focus np, Abluminus np, Cynosure. The license holder is Envision Scientific Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.